{
 "PrintNo":"A2312","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2021-01-14T11:42:43.916025Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-14","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":520,"Name":"Linda Rosenthal","Short":"ROSENTHAL L"}],
 "Title":"Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals",
 "Summary":"Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals; provides for expanded use of epinephrine auto-injector devices in schools in emergency circumstances.",
 "LawSection":"Public Health Law","LawCode":"Amd §§3000-a & 3000-c, add §3000-e, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to use of epinephrine auto-injector devices in schools and authorizing the use of glucagon for emergency injection kits",
 "PreviousVersions":["A7041-2013","A197-2015","A679-2017","A1138-2019"]
}